Polo-like kinases and oncogenesis

Polo-like kinases (Plks) play pivotal roles in the regulation of cell cycle progression. Plk1, the best characterized family member among mammalian Plks, strongly promotes the progression of cells through mitosis. Furthermore, Plk1 is found to be overexpressed in a variety of human tumors and its expression correlates with cellular proliferation and prognosis of tumor patients. Although all Plks share two conserved elements, the N-terminal Ser/Thr kinase domain and a highly homologues C-terminal region termed the polo-box motif, their functions diverge considerably. While Plk1 is inhibited by different checkpoint pathways, Plk2 and Plk3 are activated by the spindle checkpoint or the DNA damage checkpoint. Thus, Plk2 and Plk3 seem to inhibit oncogenic transformation. Deregulation of Plk1 activity contributes to genetic instability, which in turn leads to oncogenic transformation. In contrast, Plk2 and Plk3 are involved in checkpoint-mediated cell cycle arrest to ensure genetic stability, thereby inhibiting the accumulation of genetic defects. In this review, we shall discuss the roles of Plks in oncogenesis and Plk1 as a target for therapeutic intervention against cancer.

[1]  Kyung S. Lee,et al.  A Spindle Checkpoint Arrest and a Cytokinesis Failure by the Dominant-negative Polo-box Domain of Plk1 in U-2 OS Cells* 210 , 2002, The Journal of Biological Chemistry.

[2]  R. Hollingsworth,et al.  Genotoxic Stress-Induced Activation of Plk3 is Partly Mediated by Chk2 , 2002, Cell cycle.

[3]  H. Ackermann,et al.  Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer , 1997, Oncogene.

[4]  R. Wolthuis,et al.  Polo-like Kinase-1 Is Required for Bipolar Spindle Formation but Is Dispensable for Anaphase Promoting Complex/Cdc20 Activation and Initiation of Cytokinesis* , 2004, Journal of Biological Chemistry.

[5]  Michael B. Yaffe,et al.  The Molecular Basis for Phosphodependent Substrate Targeting and Regulation of Plks by the Polo-Box Domain , 2003, Cell.

[6]  Xiaoqi Liu,et al.  Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Bereiter-Hahn,et al.  Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1 , 2002, Oncogene.

[8]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[9]  Y. Terada,et al.  Phosphorylation of Threonine 210 and the Role of Serine 137 in the Regulation of Mammalian Polo-like Kinase* , 2002, The Journal of Biological Chemistry.

[10]  B. Li,et al.  Human Prk Is a Conserved Protein Serine/Threonine Kinase Involved in Regulating M Phase Functions* , 1997, The Journal of Biological Chemistry.

[11]  S. Elledge,et al.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.

[12]  Akira Nakagawara,et al.  Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation* , 2004, Journal of Biological Chemistry.

[13]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[14]  H. Lane,et al.  On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. , 1997, Biochemical and biophysical research communications.

[15]  R. Shiekhattar,et al.  A Human BRCA2 Complex Containing a Structural DNA Binding Component Influences Cell Cycle Progression , 2001, Cell.

[16]  R. Medema,et al.  Inhibition of Polo-like Kinase-1 by DNA Damage Occurs in an ATM- or ATR-dependent Fashion* , 2001, The Journal of Biological Chemistry.

[17]  E. Nigg,et al.  Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis , 2003, The Journal of cell biology.

[18]  Jürgen Bereiter-Hahn,et al.  Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. , 2002, Journal of the National Cancer Institute.

[19]  D. Slamon,et al.  prk, a Cytokine-inducible Human Protein Serine/Threonine Kinase Whose Expression Appears to be Down-regulated in Lung Carcinomas* , 1996, The Journal of Biological Chemistry.

[20]  Xiaoqi Liu,et al.  Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Venkitaraman,et al.  Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression , 2004, Oncogene.

[22]  C. McGowan,et al.  Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways , 2002, Oncogene.

[23]  J. Dennis,et al.  The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization , 2002, Nature Structural Biology.

[24]  N. Takai,et al.  Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. , 2001, Cancer letters.

[25]  H. Lane,et al.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes , 1996, The Journal of cell biology.

[26]  R. Kaufmann,et al.  Expression of polo‐like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease , 2002, Journal of cutaneous pathology.

[27]  K. Strebhardt,et al.  Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. , 2004, Journal of the National Cancer Institute.

[28]  H. Wang,et al.  Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. , 1999, Science.

[29]  S. Elledge,et al.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Stern,et al.  Polo-like Kinase 1 and Chk2 Interact and Co-localize to Centrosomes and the Midbody* , 2003, The Journal of Biological Chemistry.

[31]  E. Bahassi,et al.  Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation , 2004, Oncogene.

[32]  W. Dai,et al.  The physical association and phosphorylation of Cdc25C protein phosphatase by Prk , 1999, Oncogene.

[33]  W. Beauregard,et al.  Milk of calcium cholecystitis. , 1980, The Journal of pediatrics.

[34]  J. Dennis,et al.  Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Grobholz,et al.  Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer. , 2000, Pathology, research and practice.

[36]  Xiaoqi Liu,et al.  Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1 , 2004, Journal of Cell Science.

[37]  J. Wiest,et al.  Intron/Exon organization and polymorphisms of the PLK3/PRK gene in human lung carcinoma cell lines , 2001, Genes, chromosomes & cancer.

[38]  S. Elledge,et al.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2. , 2000, Science.

[39]  S. Loening,et al.  Polo‐like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades , 2004, The Prostate.

[40]  J. Qin,et al.  M Phase-specific Phosphorylation of BRCA2 by Polo-like Kinase 1 Correlates with the Dissociation of the BRCA2-P/CAF Complex* , 2003, Journal of Biological Chemistry.

[41]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[42]  David M. Glover,et al.  Metaphase Arrest with Centromere Separation in polo Mutants of Drosophila , 2001, The Journal of cell biology.

[43]  A. Miyauchi,et al.  Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma , 2004, British Journal of Cancer.

[44]  W. Dai,et al.  Plk3 Functionally Links DNA Damage to Cell Cycle Arrest and Apoptosis at Least in Part via the p53 Pathway* , 2001, The Journal of Biological Chemistry.

[45]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[46]  T. Karn,et al.  Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Bartek,et al.  Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent Phosphorylation of Chk1 on Ser-317 in Response to Ionizing Radiation* , 2003, The Journal of Biological Chemistry.

[49]  Steven P. Angus,et al.  Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1* , 2004, Journal of Biological Chemistry.

[50]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[51]  D. Glover,et al.  Drosophila Polo Kinase Is Required for Cytokinesis , 1998, The Journal of cell biology.

[52]  H. Ribbert,et al.  Zur Frage der Entstehung maligner Tumoren , 1914, Naturwissenschaften.

[53]  F. Traganos,et al.  Polo-like kinases and centrosome regulation , 2002, Oncogene.

[54]  Y. Shiloh,et al.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Dennis,et al.  Comparative Expression of the Mitotic Regulators SAK and PLK in Colorectal Cancer , 2001, Annals of Surgical Oncology.

[56]  T. Stokke,et al.  Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1 , 2003, Oncogene.

[57]  S. Loibl,et al.  Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells , 2002, Oncogene.

[58]  Y. Shimizu-Yoshida,et al.  Radiation-inducible hSNK gene is transcriptionally regulated by p53 binding homology element in human thyroid cells. , 2001, Biochemical and biophysical research communications.

[59]  K. Strebhardt,et al.  Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells , 2004, Oncogene.

[60]  M. Rehli,et al.  Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages , 2000, Oncogene.

[61]  A. Wilks,et al.  Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  N. Takai,et al.  Polo-like kinase (PLK) expression in endometrial carcinoma. , 2001, Cancer letters.

[63]  J. Charron,et al.  Role of Plk2 (Snk) in Mouse Development and Cell Proliferation , 2003, Molecular and Cellular Biology.

[64]  E. Nishida,et al.  Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase , 2001, Nature.

[65]  W. Weichert,et al.  Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma , 2004, British Journal of Cancer.

[66]  R. Erikson,et al.  Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  S. Zeuzem,et al.  Polo-like kinase1, a new target for antisense tumor therapy. , 2000, Biochemical and biophysical research communications.

[68]  D. Longo,et al.  Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. , 1997, Biochemical and biophysical research communications.

[69]  Y. Li,et al.  PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer , 2000, Genes, chromosomes & cancer.